Interview by Channel NewsAsia on Cancer vaccine trial in Singapore

Channel NewsAsia

“There are absolutely no side effects, so in a sense that is already a victory in itself”, says National Cancer Centre Singapore Deputy Director Dr Toh Han Chong. 

Singapore gained another achievement in the field of research as it takes its breakthrough in cancer research. With the aim of boosting the body’s immune system, a vaccine trial has been conducted in Singapore which resulted to no major side effects on the four patients with Stage 4 cancer. This is the first in history and the National Cancer Centre Singapore is looking forward to moving on to the next phase of the research.

Original article from Channel NewsAsia

It’s good news that the early results of cancer vaccine trial conducted in Singapore looks promising. 

Our Co-Founder Editor was interviewed on this breakthrough achievement by Channel NewsAsia. Please click HERE to find out more. 

If you are keen on finding out more on  the vaccine, please  e-mail chong.hui.shan@nccs.com.sg or call 6346-8431.

Post a Comment

Your email is kept private. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

address